Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

Unlike THC, CBG doesn’t have any great affinity for activating CB1 receptors, thus it doesn’t create a classic cannabis high in consumers—though its psychoactive efficacy may help treat certain mood disorders, including anxiety and depression. However, much like other cannabinoids, CBG does engage with the endogenous cannabinoid system both... Read more

EDMONTON, Feb. 6, 2020 /CNW/ – PRESS RELEASE – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this... Read more